Nordic Nanovector

0 followers


Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Ludvik Sandnes
Interim CEO & CFO

Ludvik Sandnes

Collapse
Jostein Dahle
Co-Founder & Chief Scientific Officer
Stein Rune Kjelby
Head of Accounting